TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10591235

Group type: EXPERIMENTAL
Intervention: Octreotide (100 microg subcutaneously)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control (nothing)
Number of subjects: 19
Study: 8764668

Group type: EXPERIMENTAL
Intervention: Dextroamphetamine (0.25 mg/kg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 1941060

Group type: EXPERIMENTAL
Intervention: Mesna
Number of subjects: 100

Group type: COMPARATOR
Intervention: Hyperhydration (forced saline diuresis)
Number of subjects: 100
Study: 7200210

Group type: EXPERIMENTAL
Intervention: Estrogen (Premarin, 2.5 mg per day)
Number of subjects: 29
Study: 29356022

Group type: EXPERIMENTAL
Intervention: Optical treatment with corrective lenses based on cycloplegic refraction for amblyopia
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Optical treatment
Number of subjects: 80
Study: 26165528

Group type: EXPERIMENTAL
Intervention: Non-rebreather mask (NRB) at 15 L·min⁻¹
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Non-rebreather mask (NRB) at 10 L·min⁻¹
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Demand valve with oronasal mask
Number of subjects: 15

Group type: COMPARATOR
Intervention: Oxygen 'head hood' (reference standard)
Number of subjects: 15
Study: 23188416

Group type: EXPERIMENTAL
Intervention: Omron HEM‐9000AI
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: SphygmoCor
Number of subjects: 33
Study: 21961941

Group type: EXPERIMENTAL
Intervention: Anidulafungin
Number of subjects: 135

Group type: COMPARATOR
Intervention: Fluconazole
Number of subjects: 135
Study: 18182467

Group type: EXPERIMENTAL
Intervention: PE + F (oral fludrocortisone, 0.2 mg)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: PE + D (oral dexamethasone, 0.75 mg)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: PE + F + D (both type I and type II agonists)
Number of subjects: 69

Group type: COMPARATOR
Intervention: PE (hyperinsulinemic euglycemic clamp)
Number of subjects: 69

Group type: COMPARATOR
Intervention: PH (hypoglycemic clamp)
Number of subjects: 69
Study: 15832428

Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy (LC)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Open cholecystectomy (OC)
Number of subjects: 80
Study: 12855334

Group type: EXPERIMENTAL
Intervention: Nerve growth factor (NGF) injection (5 microg in 0.2 ml) into the masseter muscle
Number of subjects: 0

Group type: COMPARATOR
Intervention: Buffered isotonic saline injection into the masseter muscle
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Non-injected temporalis muscles
Number of subjects: 0
Study: 10513162

Group type: EXPERIMENTAL
Intervention: Low-dose aprotinin
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (no aprotinin)
Number of subjects: 22
Study: 8708517

Group type: EXPERIMENTAL
Intervention: Estradiol valerate 2 mg/day for 21 days and Norgestrel 0.5 mg/day from day 12 to 21 for the first 8 weeks, followed by placebo for the last 8 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo for the first 8 weeks, followed by Estradiol valerate and Norgestrel for the last 8 weeks
Number of subjects: 60
Study: 1931064

Group type: EXPERIMENTAL
Intervention: Propofol anesthesia
Number of subjects: 99

Group type: COMPARATOR
Intervention: Thiopental sodium-isoflurane anesthesia
Number of subjects: 99
Study: 6814471

Group type: EXPERIMENTAL
Intervention: BHT 933 (5 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: BHT 933 (10 mg)
Number of subjects: 12
Study: 31709640

Group type: EXPERIMENTAL
Intervention: Disaster nursing preparedness training program (7 hours)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 63
Study: 30636436

Group type: EXPERIMENTAL
Intervention: TPB messages
Number of subjects: 407

Group type: EXPERIMENTAL
Intervention: Implementation intentions to avoid binge drinking
Number of subjects: 407

Group type: COMPARATOR
Intervention: Control group (no TPB messages)
Number of subjects: 407

Group type: COMPARATOR
Intervention: Control group (no implementation intentions)
Number of subjects: 407
Study: 28542675

Group type: EXPERIMENTAL
Intervention: 1 g of intravenous acetaminophen (IVAPAP)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo (100 mL saline infusion)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: IVAPAP
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 26075174

Group type: EXPERIMENTAL
Intervention: Underlay technique
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Over-underlay technique
Number of subjects: 114
Study: 23343675

Group type: EXPERIMENTAL
Intervention: Bing sweet cherries (280 g/d) for 28 days
Number of subjects: 18
Study: 21084270

Group type: EXPERIMENTAL
Intervention: Calcium (2 g/d)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (800 IU/d)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Calcium (2 g/d) and Vitamin D3 (800 IU/d)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92
Study: 19359985

Group type: EXPERIMENTAL
Intervention: Theophylline (200 to 800 mg daily for 2- to 8-month periods)
Number of subjects: 312
Study: 17540200

Group type: EXPERIMENTAL
Intervention: Fontan group (30 patients after the Fontan procedure)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Cyanotic group (29 patients with cyanotic heart disease)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Control group (26 patients with cyanotic heart disease after biventricular repair)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Patients with APCs
Number of subjects: 85
Study: 14706761

Group type: EXPERIMENTAL
Intervention: Soy isoflavones + melatonin
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: Soy isoflavones alone
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: Melatonin alone
Number of subjects: 262

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 262
Study: 11412293

Group type: EXPERIMENTAL
Intervention: Spontaneous-assisted ventilation
Number of subjects: 33

Group type: COMPARATOR
Intervention: Intermittent negative-pressure ventilation
Number of subjects: 33
Study: 9402168

Group type: EXPERIMENTAL
Intervention: Paclitaxel, Docetaxel, Epirubicin
Number of subjects: 704
Study: 8213685

Group type: EXPERIMENTAL
Intervention: 2-minute orthopedic screening examination
Number of subjects: 259

Group type: COMPARATOR
Intervention: History alone
Number of subjects: 259

Group type: COMPARATOR
Intervention: Detailed orthopedic examination
Number of subjects: 259
Study: 3802704

Group type: EXPERIMENTAL
Intervention: Carvedilol (1 mg/min for 15 minutes)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Carvedilol and labetalol
Number of subjects: 0
Study: 28011799

Group type: EXPERIMENTAL
Intervention: Post-procedural burden of supraventricular ectopic complexes (SVEC) categorized into quartiles: 0-72, 73-212, 213-782, ≥783 SVEC/day
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Post-procedural burden of SVEC (≥213) in patients with early AF recurrence <90 days after catheter ablation
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Low ectopy burden in patients with early AF recurrence
Number of subjects: 125
Study: 27631143

Group type: EXPERIMENTAL
Intervention: Neurofeedback
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 112

Group type: COMPARATOR
Intervention: Physical Activity
Number of subjects: 112
Study: 23942059

Group type: EXPERIMENTAL
Intervention: Home visits for male partner HIV counselling and testing
Number of subjects: 300

Group type: COMPARATOR
Intervention: Clinic-based invitations for male partner HIV counselling and testing
Number of subjects: 300
Study: 22475307

Group type: EXPERIMENTAL
Intervention: Food associated with familiar characters (e.g., sugary or salty snacks)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Healthy food branded with a favored character
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Character branding (favored character vs. unknown character)
Number of subjects: 0
Study: 20353747

Group type: EXPERIMENTAL
Intervention: Clopidogrel besylate (test formulation)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Clopidogrel bisulfate (reference formulation)
Number of subjects: 40
Study: 19027436

Group type: EXPERIMENTAL
Intervention: In vivo exposure therapy
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Virtual reality exposure therapy
Number of subjects: 72
Study: 15880252

Group type: COMPARATOR
Intervention: Aquatic respiratory exercise program
Number of subjects: 81

Group type: COMPARATOR
Intervention: Non-aquatic respiratory exercise program
Number of subjects: 81

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 81
Study: 12520629

Group type: EXPERIMENTAL
Intervention: Sodium oxybate (4.5 g) administered after an overnight fast
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sodium oxybate (4.5 g) administered after a high-fat meal
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sodium oxybate (4.5 g)
Number of subjects: 0
Study: 11574436

Group type: EXPERIMENTAL
Intervention: Hypoglycemia (blood glucose 2.59 [0.19] mmol/l)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Euglycemia (controlled euglycemia at 4.50 [0.22] mmol/l)
Number of subjects: 20
Study: 9166993

Group type: EXPERIMENTAL
Intervention: Electroacupuncture analgesia (EA)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Conventional meperidine analgesia (MA)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Both EA and MA
Number of subjects: 59
Study: 8243791

Group type: EXPERIMENTAL
Intervention: Budesonide 200 micrograms twice daily
Number of subjects: 120

Group type: COMPARATOR
Intervention: Beclomethasone dipropionate (BDP) 200 micrograms twice daily
Number of subjects: 120
Study: 3808875

Group type: EXPERIMENTAL
Intervention: Alcohol drink
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo drink
Number of subjects: 40
Study: 31454929

Group type: EXPERIMENTAL
Intervention: Aerobic Interval Training Group (AITG)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 52
Study: 28895142

Group type: EXPERIMENTAL
Intervention: Laparoscopic pancreatoduodenectomy
Number of subjects: 64

Group type: COMPARATOR
Intervention: Open pancreatoduodenectomy
Number of subjects: 64
Study: 25630447

Group type: EXPERIMENTAL
Intervention: EXCEL II stent system (PCI)
Number of subjects: 45
Study: 22321813

Group type: EXPERIMENTAL
Intervention: Laparoscopic pyeloplasty (LP)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Open pyeloplasty (OP)
Number of subjects: 57
Study: 21612468

Group type: EXPERIMENTAL
Intervention: Abiraterone acetate (1000 mg) with prednisone (5 mg twice daily)
Number of subjects: 1195

Group type: COMPARATOR
Intervention: Placebo with prednisone (5 mg twice daily)
Number of subjects: 1195
Study: 19218816

Group type: EXPERIMENTAL
Intervention: Omalizumab administered subcutaneously every 2 or 4 weeks based on serum IgE level and body weight.
Number of subjects: 34
Study: 16914695

Group type: EXPERIMENTAL
Intervention: Gabapentin
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 14977692

Group type: EXPERIMENTAL
Intervention: Swaddling
Number of subjects: 25

Group type: COMPARATOR
Intervention: Massage
Number of subjects: 25
Study: 11558059

Group type: EXPERIMENTAL
Intervention: Original‐Golytely‐salt
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: Oralav
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: Delcoprep
Number of subjects: 310
Study: 9770887

Group type: EXPERIMENTAL
Intervention: Helicobacter pylori (Hp) colonization
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Anti Hp IgG antibodies
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Chronic antral gastritis
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Chronic duodenitis
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Age > 10 years
Number of subjects: 31
Study: 7541176

Group type: EXPERIMENTAL
Intervention: Low PCO2
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High PCO2
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Haldane effect correction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HE-induced delta pH
Number of subjects: 0
Study: 3251481

Group type: COMPARATOR
Intervention: Safety education courses organized by agricultural and forestry organizations, Local Safety Inspectorate, and public health services; location close to participants' farms; specific details on dosage and duration not available.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Safety education courses; specific details on dosage and duration not available.
Number of subjects: 0
Study: 1999027

Group type: COMPARATOR
Intervention: Conventional protocol
Number of subjects: 293

Group type: EXPERIMENTAL
Intervention: Accelerated protocol
Number of subjects: 293
Study: 1251775

Group type: EXPERIMENTAL
Intervention: Streptokinase and heparin
Number of subjects: 15

Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 15

Group type: COMPARATOR
Intervention: Phenprocoumon
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Heparin or streptokinase
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Streptokinase
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Thrombosis in femoral and/or iliac vein
Number of subjects: 15

Group type: COMPARATOR
Intervention: Thrombosis in popliteal vein or lower
Number of subjects: 15
Study: 28494656

Group type: EXPERIMENTAL
Intervention: In-service training workshop on ADHD
Number of subjects: 274
Study: 28235531

Group type: EXPERIMENTAL
Intervention: Reduced dose (0.5mg/kg) of propofol with divided remifentanil injections and moderate hyperventilation (ETCO2 of 30‐35mmHg) (group RP/H)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard dose (1mg/kg) of propofol and normoventilation (ETCO2 of 40‐45mmHg) (group P/N)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Reduced dose (0.5mg/kg) of propofol with divided remifentanil injections and normoventilation (group RP/N)
Number of subjects: 60
Study: 25332458

Group type: EXPERIMENTAL
Intervention: Current smokers
Number of subjects: 16412

Group type: COMPARATOR
Intervention: Prescribed smoking cessation medications
Number of subjects: 16412

Group type: COMPARATOR
Intervention: Over-the-counter medications
Number of subjects: 16412

Group type: COMPARATOR
Intervention: Psychotherapy
Number of subjects: 16412
Study: 23286257

Group type: EXPERIMENTAL
Intervention: Midazolam and pentazocine (7.5 mg)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Midazolam only
Number of subjects: 160
Study: 20026871

Group type: EXPERIMENTAL
Intervention: Atomoxetine 25 to 100 mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 19563190

Group type: EXPERIMENTAL
Intervention: Fire-needle therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Electroacupuncture
Number of subjects: 60
Study: 16641466

Group type: EXPERIMENTAL
Intervention: Erythromycin (EM) susceptibility testing
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Clindamycin (CM) susceptibility testing
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Detection of ermB, ermTR, and mefA/E antibiotic resistance genes
Number of subjects: 222
Study: 15566374

Group type: EXPERIMENTAL
Intervention: Experience with a relatively easy symbolic retrieval task
Number of subjects: 3
Study: 11472278

Group type: EXPERIMENTAL
Intervention: Controlled Ventilation (CV group)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Spontaneous Breathing (SB group)
Number of subjects: 31
Study: 9723625

Group type: EXPERIMENTAL
Intervention: Vitamin E therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 7521724

Group type: EXPERIMENTAL
Intervention: Preoperative adjuvant IL-2 therapy
Number of subjects: 12

Group type: COMPARATOR
Intervention: Hepatic resection without IL-2
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Hepatic resection after IL-2 therapy
Number of subjects: 12
Study: 3050517

Group type: EXPERIMENTAL
Intervention: Vancomycin, ticarcillin, and amikacin
Number of subjects: 101
Study: 30604674

Group type: EXPERIMENTAL
Intervention: PAFAC score derived from multivariable logistic regression model
Number of subjects: 1307

Group type: EXPERIMENTAL
Intervention: PAFAC score applied to validation cohort
Number of subjects: 1307
Study: 28498189

Group type: EXPERIMENTAL
Intervention: POC CD4 testing plus CD4-specific counseling
Number of subjects: 1150

Group type: COMPARATOR
Intervention: Standard-of-care (SOC)
Number of subjects: 1150
Study: 25790213

Group type: EXPERIMENTAL
Intervention: WebTIPS program
Number of subjects: 82

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 82
Study: 24001379

Group type: EXPERIMENTAL
Intervention: BB-UVA (15 J/cm²)
Number of subjects: 40

Group type: COMPARATOR
Intervention: NB-UVB
Number of subjects: 40
Study: 21358477

Group type: EXPERIMENTAL
Intervention: Bryan cervical disc arthroplasty
Number of subjects: 48

Group type: COMPARATOR
Intervention: Anterior cervical discectomy and fusion
Number of subjects: 48
Study: 18581619

Group type: EXPERIMENTAL
Intervention: Test with 80% specificity (Sp) and any sensitivity (Se) including 100%
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Test with 90% specificity (Sp)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Test with 95% specificity (Sp) and intermediate sensitivity (Se) (40%-60%)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Test with 99% specificity (Sp) and very high sensitivity (Se) (over 90%)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Correction procedures for large bias in disease burden estimates
Number of subjects: 0
Study: 16567830

Group type: EXPERIMENTAL
Intervention: Pioglitazone 45 mg/day for 24 weeks
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 12
Study: 12601502

Group type: EXPERIMENTAL
Intervention: Active nicotine gum
Number of subjects: 296

Group type: COMPARATOR
Intervention: Inactive gum (placebo)
Number of subjects: 296
Study: 11570313

Group type: EXPERIMENTAL
Intervention: Monthly combination injectable contraceptive (estradiol cypionate and medroxyprogesterone acetate)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral contraceptive
Number of subjects: 0
Study: 9543313

Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 27

Group type: COMPARATOR
Intervention: Lorazepam
Number of subjects: 27
Study: 7821473

Group type: EXPERIMENTAL
Intervention: Ivermectin
Number of subjects: 6831

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6831
Study: 3045028

Group type: COMPARATOR
Intervention: Potassium chloride 1 g twice/day
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Amiloride 5 mg twice/day
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Triamterene 75 mg twice/day
Number of subjects: 23
Study: 31957732

Group type: EXPERIMENTAL
Intervention: Overall prevalence of blindness and severe visual impairment (VI)
Number of subjects: 3189

Group type: EXPERIMENTAL
Intervention: Leading causes of blindness and severe VI
Number of subjects: 3189

Group type: EXPERIMENTAL
Intervention: Cataract surgical coverage (CSC)
Number of subjects: 3189

Group type: EXPERIMENTAL
Intervention: Prevalence of diabetes
Number of subjects: 3189

Group type: EXPERIMENTAL
Intervention: Prevalence of diabetic retinopathy (DR)
Number of subjects: 3189
Study: 30714058

Group type: EXPERIMENTAL
Intervention: Probiotic milk chocolate (PMC)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Probiotic white chocolate (PWC)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Probiotic dark chocolate (PDC)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Conventional milk chocolate (MC)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Conventional white chocolate (WC)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Conventional dark chocolate (DC)
Number of subjects: 150
Study: 27009057

Group type: EXPERIMENTAL
Intervention: Tailored behavioural medicine treatment
Number of subjects: 97

Group type: COMPARATOR
Intervention: Exercise-based physiotherapy
Number of subjects: 97
Study: 26395257

Group type: EXPERIMENTAL
Intervention: Training for GPs in identifying patients in need of palliative care and anticipatory care planning.
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group (GPs did not receive training or coaching).
Number of subjects: 52
Study: 24364361

Group type: EXPERIMENTAL
Intervention: Ecologically Based Family Therapy (EBFT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Motivational Enhancement Therapy (MET)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Community Reinforcement Approach (CRA)
Number of subjects: 0
Study: 22999398

Group type: EXPERIMENTAL
Intervention: 4 mg enantiomeric excess hyperbaric levobupivacaine
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 6 mg enantiomeric excess hyperbaric levobupivacaine
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 8 mg enantiomeric excess hyperbaric levobupivacaine
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: All doses of enantiomeric excess hyperbaric levobupivacaine
Number of subjects: 120
Study: 19528195

Group type: EXPERIMENTAL
Intervention: PROSPECT intervention
Number of subjects: 599

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 599
Study: 17391147

Group type: EXPERIMENTAL
Intervention: Insulin detemir
Number of subjects: 0

Group type: COMPARATOR
Intervention: Neutral protamine Hagedorn (NPH) insulin
Number of subjects: 0
Study: 15465626

Group type: EXPERIMENTAL
Intervention: Glycerophosphocholine (GPCh) in Alzheimer's patients
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Phosphocholine (PCh) in Alzheimer's patients
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Free choline (Ch) in Alzheimer's patients
Number of subjects: 30

Group type: COMPARATOR
Intervention: Phosphocholine (PCh) in vascular dementia patients
Number of subjects: 30
Study: 11394558

Group type: EXPERIMENTAL
Intervention: Motivation-matched intervention with feedback reports tailored to psychological variables
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard, print-based intervention
Number of subjects: 0
Study: 9442340

Group type: EXPERIMENTAL
Intervention: Haloperidol
Number of subjects: 26

Group type: COMPARATOR
Intervention: Clozapine
Number of subjects: 26
Study: 7766785

Group type: EXPERIMENTAL
Intervention: Screening intervention (exact details not provided)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Catch-up time method
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard logrank test
Number of subjects: 0